- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CRIS
Recent news which mentions CRIS
From Benzinga
From Benzinga
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
March 06, 2023
From Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 12, 2022
From Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
December 12, 2022
From Benzinga
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
September 26, 2022
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
From Benzinga
Curis Resumes Enrollment In Monotherapy TakeAim Leukemia Study, Combo Phase Still Under Partial Hold
August 30, 2022
Tickers
CRIS
From Benzinga
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
From Benzinga
Curis (CRIS) announces that the FDA has lifted the partial clinical hold on Emavusertib’s TakeAim Lymphoma Study.
August 18, 2022
Tickers
CRIS
From Best Stocks
Dow Falls 60 Points; Crude Oil Rises Sharply
August 18, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 18, 2022
From Benzinga
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
August 18, 2022
From Benzinga
BLUE Stock Moves as FDA Approves Bluebird Bio’s Gene Therapy
August 18, 2022
From InvestorPlace
U.S. Stocks Turn Higher; Nasdaq Rises 50 Points
August 18, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 18, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.